Skip to main content
FinSpry Logo
FinSpry
AUTL logo
AUTL
(NASDAQ)
Autolus Therapeutics plc
$1.41-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Autolus Therapeutics (AUTL) Stock Price & Financial Analysis

Autolus Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$1.31 - $1.42
52-Week High$2.70
52-Week Low$1.11
Open$1.33
Volume1.03M
Average Volume (3M)1.03M
Market Cap375.26M
Shares Outstanding266.14M
Price to Sales (P/S)7.18
Price to Book (P/B)1.38
EV/EBITDA-1.50
Revenue (TTM)51.13M
Net Income (TTM)-224.80M
Free Cash Flow (TTM)-306.05M
EPS (TTM)$-0.84
Profit Margin-439.68%
Operating Margin-535.79%
Return on Equity (ROE)-84.69%
Debt to Equity0.25
50-Day MA$1.48
200-Day MA$1.70
52-Week Change-2.13%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Autolus Therapeutics

What is the current stock price for AUTL?

As of the latest trading session, AUTL stock trades at $1.41. The 52-week range is $1.11–$2.70, with a day range of $1.31–$1.42.

What is the P/E ratio for AUTL?

The P/E ratio (Price-to-Earnings) for AUTL is shown in the Key Statistics section. This valuation metric helps compare Autolus Therapeutics plc to industry peers.

Does AUTL pay dividends?

Autolus Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for AUTL?

Based on 6 analysts, the consensus for AUTL is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of AUTL?

Autolus Therapeutics's market capitalization is $375.3M, classifying it as a small-cap company. Autolus Therapeutics operates in the Healthcare sector within the Biotechnology industry.